IMVT Stock Analysis: Buy, Sell, or Hold?

IMVT - Immunovant, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$38.79
0.65 (1.70%) ▲
5d: +1.44%
30d: +25.45%
90d: +54.54%
HOLD
MODERATE Confidence
Protect Your IMVT Gains
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution

None View Scanner →

Strength: 8.0/10

Get Alerted When IMVT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IMVT is currently trading at $38.79, which is considered extended relative to its 30-day fair value range of $30.45 to $36.52.

Technical Outlook: Technically, IMVT is in a strong uptrend. The price is approaching resistance at $39.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: IMVT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.76 (+18.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $30.45 - $36.52
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 55.3%

Protect Your Profits

Holding IMVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+6.2% above its trading range)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($45.76)

Trading Range Analysis

30-Day Trading Range $30.45 - $36.52
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $34.40
Resistance Level $39.28
Current Trend Strong Uptrend
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -15.01
Wall Street Target $45.76 (+18.0%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 10:32 PM ET
Data refreshes hourly during market hours. Next update: 11:32 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao SELL 25760 shares 2026-04-23
Jay S Stout SELL 2754 shares 2026-04-23
Jay S Stout SELL 10132 shares 2026-04-08

Unlock Insider Activity

See real-time buying/selling by company executives for IMVT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 56 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$106 64 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 54 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$110 61 BUY
CLDX
Celldex Therapeutics Inc
STRONG BUY
15 analysts
$58 57 HOLD

Advanced IMVT Option Strategies

Professional options setups generated by AI based on today's IMVT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for IMVT

IMVT Technical Chart IMVT Price Prediction IMVT Earnings Date IMVT Investment Advisor IMVT Fair Price Analyzer IMVT Options Advisor IMVT Options Chain IMVT Options Analysis IMVT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals